The test generates results within 20 minutes and can be used by adults and children over the age of two years old.
The real-time bioaerosol sampling system can detect a very low concentration of SARS-CoV-2 in the air.
A review of new, successful treatment options for the novel coronavirus.
Lucira Health’s single-use molecular test kit will be available for prescription home use in people age 14 and older.
The serology test is the first of its kind to detect neutralizing antibodies from a recent or prior SARS-CoV-2 infection.
Combining “fit, filtration and efficiency” is the key to enhancing protection and encouraging compliance.
In order to meet the worldwide need for faster and affordable testing processes, companies must shift goals and apply resources to ending this pandemic.
The authorization is a step toward broad screening that will help reopen schools and workplaces in America, says FDA Commissioner Stephen Hahn, M.D.
Illumina’s COVIDSeq Test enables qualitative detection of SARS-CoV-2 RNA from respiratory specimens.
COVID-19 requires us to rethink our current device disinfection procedure.